Vectus Biosystems Limited is a limited by shares Australian public company. Located at NSW 2018 since 2014-09-23 the company is, as the updated on 2020-12-04 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2006-10-01. Known company numbers for Vectus Biosystems Limited are as follows: ACN - 117526137, Australian Business Number - 54117526137. Vectus Biosystems Limited has been the company name since 2016-02-22. Their official company name changed on 2012-11-09 to Vectus Biosystems Limited. Additionally they had used Vectus Biosystems Pty Ltd from 2009-11-03 to 2012-11-09, Vectus Biosystems Limited from 2005-12-12 to 2009-11-03. This Australian public company was previously located in NSW 2018 (from 2014-01-17 to 2014-09-23), NSW 2018 (from 2005-12-12 to 2014-01-17).
| Status | From | To |
|---|---|---|
| Active | 2005-12-12 | current |
| Name | From | To |
|---|---|---|
| Vectus Biosystems Ltd | 2015-04-24 | current |
| Vectus Biosystems Limited | 2012-11-09 | current |
| Vectus Biosystems Pty Ltd | 2009-11-03 | 2012-11-09 |
| Vectus Biosystems Limited | 2005-12-12 | 2009-11-03 |
| Location | From | To |
|---|---|---|
| NSW 2018 | 2014-09-23 | current |
| NSW 2018 | 2014-01-17 | 2014-09-23 |
| NSW 2018 | 2005-12-12 | 2014-01-17 |
| Status | From | To |
|---|---|---|
| Registered | 2006-10-01 | current |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 9/00 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 9 - drugs for disorders of the cardiovascular system |
IP Australia process information:
| Expiry date: | 2026-12-08 |
General information:
| Patent status: |
Accepted Found to have no further lawful grounds of objection by the examiner. For innovation patents, acceptance is automatic following payment of fees. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61P 13/12 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | P - specific therapeutic activity of chemical compounds or medicinal preparations |
| Main group code: | 13 - drugs for disorders of the urinary system (diuretics a61p0007100000) |
| Subgroup code: | 12 - of the kidneys |
IP Australia process information:
| Expiry date: | 2029-10-16 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61K 38/22 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000) |
| Subgroup code: | 22 - hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin a61k0038330000, e.g. corticotropin a61k0038350000) |
IP Australia process information:
| Expiry date: | 2025-06-10 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.